4//SEC Filing
McLaughlin Matthew T E 4
Accession 0001437749-19-006888
CIK 0001586049other
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 4:55 PM ET
Size
6.6 KB
Accession
0001437749-19-006888
Insider Transaction Report
Form 4
McLaughlin Matthew T E
Chief Financial Officer
Transactions
- Award
Share Option (Right to Buy)
2019-04-08+57,108→ 57,108 totalExercise: $15.97Exp: 2029-04-08→ Ordinary Shares (57,108 underlying) - Award
Ordinary Shares
2019-04-08+26,612→ 26,612 total
Footnotes (2)
- [F1]Options granted under Issuer's 2013 Share Incentive Plan.
- [F2]Options will become exercisable ratably on the anniversary of the vesting start date from May 1, 2020 through May 1, 2023.
Documents
Issuer
Oxford Immunotec Global PLC
CIK 0001586049
Entity typeother
Related Parties
1- filerCIK 0001773442
Filing Metadata
- Form type
- 4
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 4:55 PM ET
- Size
- 6.6 KB